This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
OGFOD3 Polyclonal Antibody
catalog :
PA5-69640
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
rat
application :
western blot
product information
Product Type :
Antibody
Product Name :
OGFOD3 Polyclonal Antibody
Catalog # :
PA5-69640
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity chromatography
Host :
Rabbit
Reactivity :
Rat
Applications :
Western Blot: 1.0 ug/mL
Species :
Rat
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
OGFOD3 gene ontology annotations related to this gene include dioxygenase activity; iron ion binding; L-ascorbic acid binding; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen.
Immunogen :
synthetic peptide directed towards the N-terminal region of rat OGFOD3
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1.0 ug/mL
Aliases :
1110031I02Rik; 2-oxoglutarate and iron dependent oxygenase domain containing 3; 2-oxoglutarate and iron-dependent oxygenase domain containing 3; 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3; C17orf101; Ogfod3; PKHD domain-containing transmembrane protein C17orf101; PKHD domain-containing transmembrane protein C17orf101 homolog; RGD1305007
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments